U 89232
Alternative Names: BMS 189365Latest Information Update: 15 Jan 2008
Price :
$50 *
At a glance
- Originator Bristol-Myers Squibb
- Developer Pharmacia Corporation
- Class Anti-ischaemics; Guanidines; Ischaemic heart disorder therapies
- Mechanism of Action Potassium channel agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Ischaemic heart disorders